Evidence map›Paper›PMID 38047368›Full record

ArticleBiomaterials science2024

Milk exosomes anchored with hydrophilic and zwitterionic motifs enhance mucus permeability for applications in oral gene delivery.

Chenzhen Zhang, Hengli Zhang, Héctor A Millán Cotto, Timothy L Boyer, Matthew R Warren, Chia-Ming Wang, Joshua Luchan, Pradeep K Dhal, Rebecca L Carrier, Ambika G Bajpayee

Open access · greenAbstract read
In one paragraph

Article in Biomaterials science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chenzhen ZhangDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.ORCID http://orcid.org/0000-0003-0800-1908
Hengli ZhangDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.ORCID http://orcid.org/0009-0000-0918-8204
Héctor A Millán CottoDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.
Timothy L BoyerDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.ORCID http://orcid.org/0000-0002-1761-1612
Matthew R WarrenDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.ORCID http://orcid.org/0000-0002-8458-7464
Chia-Ming WangDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.ORCID http://orcid.org/0009-0007-0016-600X
Joshua LuchanDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.
Pradeep K DhalSanofi SA Global R&D, Waltham, MA, 02451, USA.ORCID http://orcid.org/0000-0002-7059-855X
Rebecca L CarrierDepartment of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.
Ambika G BajpayeeDepartment of Bioengineering, Northeastern University, Boston, MA, 02115, USA. a.bajpayee@northeastern.edu.ORCID http://orcid.org/0000-0002-2581-2633
Northeastern University · USSanofi (United States) · US

Funding

Impact of Lipids on Compound Absorption: Mechanistic Studies and ModelingR01GM098117 · NIGMS · NORTHEASTERN UNIVERSITY · PI CARRIER, REBECCA L · 2012 to 2021
$3.3M
Anti-catabolic drug anchored cationic exosomes for cartilage targeting and repairR21EB028385 · NIBIB · NORTHEASTERN UNIVERSITY · PI BAJPAYEE, AMBIKA GOEL · 2019 to 2021
$628k
NIBIB NIH HHS R21 EB028385NIGMS NIH HHS R01 GM098117
6 · The paper itself

Abstract

Exosomes have emerged as a promising tool for the delivery of drugs and genetic materials, owing to their biocompatibility and non-immunogenic nature. However, challenges persist in achieving successful oral delivery due to their susceptibility to degradation in the harsh gastrointestinal (GI) environment and impeded transport across the mucus-epithelium barrier. To overcome these challenges, we have developed high-purity bovine milk exosomes (mExo) as a scalable and efficient oral drug delivery system, which can be customized by incorporating hydrophilic and zwitterionic motifs on their surface. In our study, we observed significantly improved transport rates by 2.5-4.5-fold in native porcine intestinal mucus after the introduction of hydrophilic and zwitterionic surface modifications, as demonstrated by transwell setup and fluorescence recovery after photobleaching (FRAP) analysis. Remarkably, mExo functionalized by a block peptide (BP), consisting of cationic and anionic amino acids arranged in blocks at the two ends, demonstrated superior tolerability in the acidic gastric environment (with a protein recovery rate of 84.8 ± 7.7%) and exhibited a 2.5-fold increase in uptake by intestinal epithelial cells. Furthermore, both mExo and mExo-BP demonstrated successful intracellular delivery of functional siRNA, resulting in up to 65% suppression of the target green fluorescence protein (GFP) gene expression at a low dose of siRNA (5 pmol) without causing significant toxicity. These findings highlight the immense potential of modifying mExo with hydrophilic and zwitterionic motifs for effective oral delivery of siRNA therapies.

Indexed as

ExosomesNanoparticlesAdministration, OralAnimalsDrug CarriersDrug Delivery SystemsMilkMucusPeptidesPermeabilityRNA, Small InterferingSwineDrug CarriersPeptidesRNA, Small Interfering

Identifiers

PMID38047368
PMCPMC10842862
OpenAlexW4388942318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.